70% of the antibiotics on the market comes from bacteria that live in the soil, yet only one new class of antibiotics has been found in the past 40 years.
Currently laboratory practices can only access 5-10% of the medicines microbes have the potential to produce. With our chemical elicitation platform, we speak to bacteria in the chemical language they understand, and access up to 90% of the new drugs locked in their DNA. We gain exclusive access to the largest bio-reservoir of potential drugs on the planet, and are focused on finding molecules that treat gram-negative bacterial infections.
YOU MIGHT ALSO BE INTERESTED IN